The Latest Cardiac and Vascular News
Ghent, Belgium – 3 November 2021 – Sequana Medical NV (Euronext Brussels: SEQUA, the “Company”), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, today announces it has received Medical Device Single Audit Program (MDSAP) certification from its auditing organisation British Standards Institution (BSI), thereby expanding its […]
Study evaluates safety and performance of endovascular pulmonary nerve stimulation in ADHF MINNEAPOLIS, Nov. 2, 2021 /PRNewswire/ — Cardionomic, Inc., a Minneapolis medical device company, is pleased to announce initial U.S. enrollment in their global Cardiac Pulmonary Nerve Stimulation (CPNS) Pilot Study (NCT04814134). The study is evaluating the safety and performance of the CPNS System […]
– More than 3 million people in the US have severe hypertriglyceridemia – The CORE Phase 3 clinical study further expands Ionis’ late-stage pipeline and is the second Phase 3 clinical study in Ionis’ broad olezarsen development program – Olezarsen is one of Ionis’ wholly owned medicines the company plans […]
HU6 was well tolerated and increased resting energy expenditure Dose dependent weight loss and an improvement in metabolic parameters were also observed, despite the study not being powered to demonstrate them Enrollment for a Phase 2a Metabolic Trial of HU6 has completed with topline data expected in Q1 2022 HU6 […]
David Seth Feldman, MD, PhD, FACC, FAHA, named new Section Chief of Advanced Heart Failure Treatment and Transplantation NEWARK, N.J., Nov. 1, 2021 /PRNewswire/ — Newark Beth Israel Medical Center, an RWJBarnabas Health facility, has named David Seth Feldman, MD, PhD, FACC, FAHA, the new Section Chief of Advanced Heart Failure Treatment and Transplantation. […]
BOULDER, Colo., Nov. 01, 2021 (GLOBE NEWSWIRE) — SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a strategic collaboration with one of the nation’s leading academic medical centers, University Hospitals Cleveland Medical Center, where they will evaluate the impact of the company’s SomaSignal™ tests on the medical […]
BAINBRIDGE ISLAND, Wash.–(BUSINESS WIRE)–ReValve Solutions, Inc., an innovator in the field of transcatheter structural heart replacement and repair, announced today it has successfully completed the first human use of its transcatheter, Palmetto System for mitral valve replacement. The patient was successfully treated who suffered from severe mitral valve regurgitation and […]
NEUCHATEL, Switzerland–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) today announced Dual SET® Pulse Oximetry for Root®, a highly versatile patient monitoring and connectivity hub. The first application of Dual SET® Oximetry is a significant advancement to Masimo SET®-guided critical congenital heart disease (CCHD) screening, with the CE marking and European launch of the Masimo SET® MOC-9® module and […]
Chest Pain Guidelines also elevate coronary CT as the only first-line test for many patients REDWOOD CITY, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) — HeartFlow, Inc., the leader in revolutionizing precision heart care, today welcomed new clinical practice guidelines from the American College of Cardiology (ACC) and American Heart Association (AHA) that recognized […]
SOUTH SAN FRANCISCO, Calif., Oct. 29, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that preclinical data relating to the discovery and optimization of CK-3828136 (CK-136) were presented at the 2021 Medicinal Chemistry Gordon Research Conference in West Dover, VT. CK-136 is a novel, selective cardiac troponin activator […]
